265 related articles for article (PubMed ID: 25339225)
21. Amino terminal domains of the NMDA receptor are organized as local heterodimers.
Lee CH; Gouaux E
PLoS One; 2011 Apr; 6(4):e19180. PubMed ID: 21544205
[TBL] [Abstract][Full Text] [Related]
22. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
[TBL] [Abstract][Full Text] [Related]
23. Arrangement of subunits in functional NMDA receptors.
Salussolia CL; Prodromou ML; Borker P; Wollmuth LP
J Neurosci; 2011 Aug; 31(31):11295-304. PubMed ID: 21813689
[TBL] [Abstract][Full Text] [Related]
24. Identification of AICP as a GluN2C-Selective
Jessen M; Frederiksen K; Yi F; Clausen RP; Hansen KB; Bräuner-Osborne H; Kilburn P; Damholt A
Mol Pharmacol; 2017 Aug; 92(2):151-161. PubMed ID: 28588066
[No Abstract] [Full Text] [Related]
25. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
[TBL] [Abstract][Full Text] [Related]
26. Separate intramolecular targets for protein kinase A control N-methyl-D-aspartate receptor gating and Ca2+ permeability.
Aman TK; Maki BA; Ruffino TJ; Kasperek EM; Popescu GK
J Biol Chem; 2014 Jul; 289(27):18805-17. PubMed ID: 24847051
[TBL] [Abstract][Full Text] [Related]
27. Mg2+ block properties of triheteromeric GluN1-GluN2B-GluN2D NMDA receptors on neonatal rat substantia nigra pars compacta dopaminergic neurones.
Huang Z; Gibb AJ
J Physiol; 2014 May; 592(10):2059-78. PubMed ID: 24614743
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site.
Kvist T; Steffensen TB; Greenwood JR; Mehrzad Tabrizi F; Hansen KB; Gajhede M; Pickering DS; Traynelis SF; Kastrup JS; Bräuner-Osborne H
J Biol Chem; 2013 Nov; 288(46):33124-35. PubMed ID: 24072709
[TBL] [Abstract][Full Text] [Related]
29. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
Riou M; Stroebel D; Edwardson JM; Paoletti P
PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
[TBL] [Abstract][Full Text] [Related]
30. Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function.
Punnakkal P; Jendritza P; Köhr G
Neuropharmacology; 2012 Apr; 62(5-6):1985-92. PubMed ID: 22245680
[TBL] [Abstract][Full Text] [Related]
31. Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
Tajima N; Karakas E; Grant T; Simorowski N; Diaz-Avalos R; Grigorieff N; Furukawa H
Nature; 2016 Jun; 534(7605):63-8. PubMed ID: 27135925
[TBL] [Abstract][Full Text] [Related]
32. Single-Molecule Patch-Clamp FRET Anisotropy Microscopy Studies of NMDA Receptor Ion Channel Activation and Deactivation under Agonist Ligand Binding in Living Cells.
Sasmal DK; Yadav R; Lu HP
J Am Chem Soc; 2016 Jul; 138(28):8789-801. PubMed ID: 27270213
[TBL] [Abstract][Full Text] [Related]
33. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
[TBL] [Abstract][Full Text] [Related]
34. Two gates mediate NMDA receptor activity and are under subunit-specific regulation.
Amin JB; He M; Prasad R; Leng X; Zhou HX; Wollmuth LP
Nat Commun; 2023 Mar; 14(1):1623. PubMed ID: 36959168
[TBL] [Abstract][Full Text] [Related]
35. Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain.
Zhu S; Stroebel D; Yao CA; Taly A; Paoletti P
Nat Struct Mol Biol; 2013 Apr; 20(4):477-85. PubMed ID: 23454977
[TBL] [Abstract][Full Text] [Related]
36. Subunit-selective allosteric inhibition of glycine binding to NMDA receptors.
Hansen KB; Ogden KK; Traynelis SF
J Neurosci; 2012 May; 32(18):6197-208. PubMed ID: 22553026
[TBL] [Abstract][Full Text] [Related]
37. Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors.
Bledsoe D; Vacca B; Laube B; Klein BG; Costa B
Eur J Pharmacol; 2019 Feb; 844():216-224. PubMed ID: 30553788
[TBL] [Abstract][Full Text] [Related]
38. The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors.
Mesic I; Madry C; Geider K; Bernhard M; Betz H; Laube B
Neuropharmacology; 2016 Jun; 105():133-141. PubMed ID: 26777280
[TBL] [Abstract][Full Text] [Related]
39. GluN1-specific redox effects on the kinetic mechanism of NMDA receptor activation.
Talukder I; Kazi R; Wollmuth LP
Biophys J; 2011 Nov; 101(10):2389-98. PubMed ID: 22098737
[TBL] [Abstract][Full Text] [Related]
40. Glutamate but not glycine agonist affinity for NMDA receptors is influenced by small cations.
Nahum-Levy R; Tam E; Shavit S; Benveniste M
J Neurosci; 2002 Apr; 22(7):2550-60. PubMed ID: 11923420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
